B.P.S. Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -1.92%
- Profit Growth -285.49%
- Ebitda 25.42%
- Net Worth -47.30%
- Total Assets -16.07%
About B.P.S. Pharmaceutical
B.P.S. Pharmaceutical Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2014 and has a history of 11 years. Its registered office is in Ballia, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saraswati Prajapati and Babloo Prajapati serve as directors at the Company.
Company Details
-
Location
Ballia, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100UP2014PTC062465
-
Company No.
062465
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at B.P.S. Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saraswati Prajapati
|
Director | 04-Feb-2014 | Current |
|
Babloo Prajapati
|
Director | 04-Feb-2014 | Current |
Financial Performance of B.P.S. Pharmaceutical.
B.P.S. Pharmaceutical Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.92% decrease. The company also saw a substantial fall in profitability, with a 285.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 47.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B.P.S. Pharmaceutical?
In 2017, B.P.S. Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B.P.S. Pharmaceutical?
Unlock and access historical data on people associated with B.P.S. Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B.P.S. Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B.P.S. Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.